Agilent Technologies Return on Tangible Equity 2010-2025 | A
Current and historical return on tangible equity values for Agilent Technologies (A) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Agilent Technologies Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-04-30 | $1.17B | $1.17B | 99.85% |
| 2025-01-31 | $1.26B | $1.08B | 94.34% |
| 2024-10-31 | $1.29B | $0.87B | 85.48% |
| 2024-07-31 | $1.41B | $1.55B | 86.05% |
| 2024-04-30 | $1.24B | $1.83B | 81.52% |
| 2024-01-31 | $1.24B | $1.78B | 93.94% |
| 2023-10-31 | $1.24B | $1.41B | 115.32% |
| 2023-07-31 | $1.13B | $1.07B | 132.40% |
| 2023-04-30 | $1.35B | $1.00B | 204.31% |
| 2023-01-31 | $1.32B | $0.82B | 277.07% |
| 2022-10-31 | $1.25B | $0.53B | 370.18% |
| 2022-07-31 | $1.33B | $0.29B | 422.93% |
| 2022-04-30 | $1.26B | $0.27B | 561.33% |
| 2022-01-31 | $1.21B | $0.26B | 1258.49% |
| 2021-10-31 | $1.21B | $0.43B | 928.98% |
| 2021-07-31 | $0.99B | $-0.06B | 750.00% |
| 2021-04-30 | $0.93B | $-0.25B | 339.76% |
| 2021-01-31 | $0.81B | $0.40B | 202.12% |
| 2020-10-31 | $0.72B | $0.44B | 204.84% |
| 2020-07-31 | $0.69B | $0.50B | 273.12% |
| 2020-04-30 | $0.68B | $0.27B | 166.38% |
| 2020-01-31 | $0.76B | $0.20B | 107.15% |
| 2019-10-31 | $1.07B | $0.05B | 107.40% |
| 2019-07-31 | $1.07B | $1.13B | 84.94% |
| 2019-04-30 | $1.12B | $1.48B | 88.67% |
| 2019-01-31 | $1.14B | $1.34B | 86.87% |
| 2018-10-31 | $0.32B | $1.11B | 23.13% |
| 2018-07-31 | $0.30B | $1.12B | 19.15% |
| 2018-04-30 | $0.24B | $1.69B | 14.09% |
| 2018-01-31 | $0.20B | $1.55B | 12.10% |
| 2017-10-31 | $0.68B | $1.87B | 43.77% |
| 2017-07-31 | $0.63B | $1.62B | 44.44% |
| 2017-04-30 | $0.58B | $1.43B | 42.70% |
| 2017-01-31 | $0.51B | $1.33B | 39.63% |
| 2016-10-31 | $0.46B | $1.31B | 37.96% |
| 2016-07-31 | $0.48B | $1.38B | 38.75% |
| 2016-04-30 | $0.46B | $1.12B | 38.66% |
| 2016-01-31 | $0.46B | $1.06B | 36.90% |
| 2015-10-31 | $0.40B | $1.36B | 30.56% |
| 2015-07-31 | $0.28B | $1.26B | 18.35% |
| 2015-04-30 | $0.31B | $1.30B | 18.82% |
| 2015-01-31 | $0.37B | $1.33B | 20.61% |
| 2014-10-31 | $0.50B | $2.15B | 27.14% |
| 2014-07-31 | $0.69B | $1.87B | 42.56% |
| 2014-04-30 | $0.71B | $1.74B | 52.01% |
| 2014-01-31 | $0.74B | $1.57B | 58.57% |
| 2013-10-31 | $0.72B | $1.33B | 61.70% |
| 2013-07-31 | $0.94B | $0.85B | 84.47% |
| 2013-04-30 | $1.01B | $1.31B | 91.47% |
| 2013-01-31 | $1.10B | $1.21B | 75.26% |
| 2012-10-31 | $1.15B | $1.07B | 64.66% |
| 2012-07-31 | $1.02B | $0.84B | 48.55% |
| 2012-04-30 | $1.10B | $2.73B | 45.53% |
| 2012-01-31 | $1.05B | $2.49B | 47.26% |
| 2011-10-31 | $1.01B | $2.32B | 51.80% |
| 2011-07-31 | $1.02B | $2.16B | 59.87% |
| 2011-04-30 | $0.89B | $1.91B | 64.48% |
| 2011-01-31 | $0.80B | $1.42B | 58.35% |
| 2010-10-31 | $0.68B | $1.29B | 46.86% |
| 2010-07-31 | $0.42B | $0.90B | 26.71% |
| 2010-04-30 | $0.19B | $1.86B | 11.00% |
| 2010-01-31 | $-0.02B | $1.79B | -0.95% |
| 2009-10-31 | $-0.03B | $1.69B | -1.87% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.241B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $221.543B | 25.98 |
| Boston Scientific (BSX) | United States | $155.948B | 37.25 |
| Stryker (SYK) | United States | $144.198B | 29.40 |
| EssilorLuxottica (ESLOY) | France | $136.878B | 0.00 |
| Medtronic (MDT) | Ireland | $114.582B | 16.24 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.915B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.396B | 24.77 |
| ResMed (RMD) | United States | $40.938B | 29.24 |
| GE HealthCare Technologies (GEHC) | United States | $31.891B | 14.99 |
| Koninklijke Philips (PHG) | Netherlands | $25.479B | 16.85 |
| Terumo (TRUMY) | Japan | $25.170B | 32.69 |
| Insulet (PODD) | United States | $20.051B | 78.70 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.929B | 11.52 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.503B | 0.00 |
| Baxter (BAX) | United States | $11.269B | 8.71 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.745B | 28.29 |
| Lantheus Holdings (LNTH) | United States | $4.882B | 12.32 |
| Perrigo (PRGO) | Ireland | $3.662B | 9.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.643B | 16.27 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Envista Holdings (NVST) | United States | $3.462B | 24.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.136B | 23.12 |
| LeMaitre Vascular (LMAT) | United States | $1.831B | 40.93 |
| AtriCure (ATRC) | United States | $1.710B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.543B | 10.61 |
| Green Thumb Industries (GTBIF) | United States | $1.429B | 32.14 |
| Acuren (TIC) | United States | $1.340B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Phibro Animal Health (PAHC) | United States | $1.058B | 13.53 |
| Neogen (NEOG) | United States | $1.012B | 16.07 |
| BioLife Solutions (BLFS) | United States | $0.995B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.954B | 0.00 |
| InMode (INMD) | Israel | $0.868B | 8.04 |
| Kestra Medical Technologies (KMTS) | United States | $0.790B | 0.00 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.590B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.572B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.565B | 0.00 |
| ZimVie (ZIMV) | United States | $0.529B | 20.39 |
| Surmodics (SRDX) | United States | $0.515B | 0.00 |
| CeriBell (CBLL) | United States | $0.511B | 0.00 |
| Owens & Minor (OMI) | United States | $0.508B | 4.21 |
| SNDL (SNDL) | Canada | $0.434B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.361B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.311B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.304B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.296B | 10.88 |
| Quanterix (QTRX) | United States | $0.293B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Cerus (CERS) | United States | $0.243B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.239B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.234B | 19.77 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Omeros (OMER) | United States | $0.223B | 0.00 |
| Brainsway (BWAY) | Israel | $0.217B | 57.35 |
| Canopy Growth (CGC) | Canada | $0.215B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.215B | 0.00 |
| Biote (BTMD) | United States | $0.213B | 5.98 |
| Vireo Growth (VREOF) | United States | $0.196B | 0.00 |
| Exagen (XGN) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.69 |
| Organigram Global (OGI) | Canada | $0.178B | 0.00 |
| High Tide (HITI) | Canada | $0.176B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.158B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.132B | 0.00 |
| Safety Shot (SHOT) | United States | $0.122B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.118B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.51 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| Zynex (ZYXI) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.71 |
| Nephros (NEPH) | United States | $0.036B | 48.86 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |